--- title: "US IPO Weekly Winners & Losers" type: "News" locale: "en" url: "https://longbridge.com/en/news/296706681.md" description: "The US IPO market is slowing for August, with Anthropic targeting an October listing and OpenAI considering Q4. New stocks faced volatility: the Renaissance IPO Index fell 4.7%, while Klarna dropped 31.1% due to lowered guidance. Conversely, Tempus AI surged 39.5% on positive trial results, and defense contractor Lyntris priced below expectations amid sector weakness." datetime: "2026-08-23T16:00:19.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/296706681.md) - [en](https://longbridge.com/en/news/296706681.md) - [zh-HK](https://longbridge.com/zh-HK/news/296706681.md) generator: "portal-rs" --- # US IPO Weekly Winners & Losers The IPO market has hit its annual August pause. The next two weeks should be **light on pricings, heavy on filings**. Anthropic continues to dominate IPO headlines. After a reported 14x increase in quarterly revenue, the AI model developer is firming up plans for a possible October listing that could raise more than SpaceX. More IPO hopefuls joined our fall watchlist, including **General Atlantic**, **Nscale**, **Kakao Mobility**, and a few public filers. Meanwhile, **OpenAI’s** CFO played down imminent IPO plans, but didn't rule out a Q4 listing either. The final IPO of the summer was a dud: Defense contractor Lyntris (NYSE: LYNX) priced below the range and ended the week off -10%. The rare Evercore-led deal hit the market amid a sell-off in defense stocks, including several recent IPOs. New stocks pulled back this week, dragged down by AI infrastructure companies amid bond-market volatility. The IPO Index retreated -4.7%, with the S&P 500 off -1.4%. Buy-now-pay-later lender **Klarna** dropped -31.1% after the company lowered guidance. AI-powered precision medicine company **Tempus AI** jumped +39.5% on positive results from partner Moderna’s cancer trial. Several digital asset plays also landed among the new stock winners. The Renaissance IPO Index returned -4.7% last week vs. -1.4% for the S&P 500. ### Related Stocks - [LYNX.US](https://longbridge.com/en/quote/LYNX.US.md) - [KLAR.US](https://longbridge.com/en/quote/KLAR.US.md) - [TEM.US](https://longbridge.com/en/quote/TEM.US.md) - [TEMT.US](https://longbridge.com/en/quote/TEMT.US.md) - [IPO.US](https://longbridge.com/en/quote/IPO.US.md) - [ANTH.NA](https://longbridge.com/en/quote/ANTH.NA.md) - [OpenAI.NA](https://longbridge.com/en/quote/OpenAI.NA.md) - [EVR.US](https://longbridge.com/en/quote/EVR.US.md) - [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md) - [MRNA.US](https://longbridge.com/en/quote/MRNA.US.md) ## Related News & Research - [Tempus AI (NASDAQ:TEM) CAO Ryan Bartolucci Sells 6,175 Shares of Stock](https://longbridge.com/en/news/296562025.md) - [Andrew Polovin Sells 22,148 Shares of Tempus AI (NASDAQ:TEM) Stock](https://longbridge.com/en/news/296610788.md) - [Tempus AI director Nadja West disposes of 3,000 common shares worth $161,700](https://longbridge.com/en/news/296265854.md) - [Anthropic's Revenue Run Rate Blows Past $65 Billion, Topping OpenAI by 62%](https://longbridge.com/en/news/296198219.md) - [Anthropic’s revenue surge puts OpenAI under pressure in enterprise AI race](https://longbridge.com/en/news/296293533.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**